428 related articles for article (PubMed ID: 21591511)
1. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
[TBL] [Abstract][Full Text] [Related]
2. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil.
Souza MA; Passos AM; Treitinger A; Spada C
Rev Soc Bras Med Trop; 2010; 43(4):359-61. PubMed ID: 20802930
[TBL] [Abstract][Full Text] [Related]
4. Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014.
Bawa MK; Mamman A; Olayinka A; Gidado S; Waziri NE; Balogun MS; Getso KI; Dalhat MM; Nsubuga P; Aliyu N; Bala H; Muhammad H; Haladu S; Shehu UL; Nguku PM
Pan Afr Med J; 2019; 32(Suppl 1):6. PubMed ID: 30984327
[TBL] [Abstract][Full Text] [Related]
5. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.
Fowotade A; Okonko IO; Agbede OO; Suleiman ST
Afr Health Sci; 2015 Mar; 15(1):1-9. PubMed ID: 25834524
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of anti-CMV antibodies in blood donors in Ouagadougou (Burkina Faso)].
Ouédraogo AS; Yaméogo JT; Poda GE; Kientega Y; Ouédraogo Traore R
Med Sante Trop; 2012; 22(1):107-9. PubMed ID: 22871792
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
Das B; Kaur G; Basu S
Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
11. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).
Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A
Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya.
Maingi Z; Nyamache AK
BMC Res Notes; 2014 Nov; 7():794. PubMed ID: 25392013
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of transfusion-transmitted infections in hospitalized patients before transfusion and volunteer blood donors in Zhejiang Province, China.
Mengjiao L; Yushan X; Yan L; Dawei C; Xiaojun Z; Yongjun W; Cuifen S; Jue X
Infect Dis Now; 2024 Mar; 54(2):104861. PubMed ID: 38316362
[TBL] [Abstract][Full Text] [Related]
15. Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study.
Preiksaitis JK; Desai S; Vaudry W; Roberts S; Akabutu J; Grundy P; Wilson B; Boshkov L; Hannon J; Joffres M
Transfusion; 1997 Sep; 37(9):941-6. PubMed ID: 9308642
[TBL] [Abstract][Full Text] [Related]
16. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
Weber B; Fall EM; Berger A; Doerr HW
J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of CMV, HSV-2 and HBV among HIV-Infected Malawian Children: A Cross-sectional Survey.
Varo R; Buck WC; Kazembe PN; Phiri S; Andrianarimanana D; Weigel R
J Trop Pediatr; 2016 Jun; 62(3):220-6. PubMed ID: 26884443
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Immunoglobulin G Avidity Index among Blood Donors in Alexandria, Egypt.
Gawad AA; Hashish M; Abaza A; El-Kayal A
Cent Eur J Public Health; 2016 Dec; 24(4):314-320. PubMed ID: 28095288
[TBL] [Abstract][Full Text] [Related]
19. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of cytomegalovirus infections in Croatia.
Vilibic-Cavlek T; Kolaric B; Beader N; Vrtar I; Tabain I; Mlinaric-Galinovic G
Wien Klin Wochenschr; 2017 Feb; 129(3-4):129-135. PubMed ID: 27599701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]